Drug Patents owned by B Braun Medical Inc

1. Drug name - CLOROTEKAL

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8969412 B BRAUN MEDICAL INC Use for a composition comprising chloroprocaine HCL, a new composition comprising chloroprocaine HCL and a method for its manufacture
Sep, 2026

(3 years from now)

US9504666 B BRAUN MEDICAL INC Chloroprocaine-based pharmaceutical composition for repeated intrathecal administration
Dec, 2033

(11 years from now)

Drugs and Companies using CHLOROPROCAINE HYDROCHLORIDE ingredient

Market Authorisation Date: 26 September, 2017

Treatment: A method for inducing a regional anaesthesia via intrathecal administration of a patented preservative free solution for injection (with a specific composition, ph, osmolality and density) containing 9-11 mg/ml chloroprocaine hcl

Dosage: SOLUTION;INTRATHECAL

More Information on Dosage
Strength Dosage Availability
50MG/5ML (10MG/ML) SOLUTION;INTRATHECAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.

Other things you might be interested in